Who We Are

The New Jersey Life Sciences Vendors Alliance (NJLSVA) is a coalition of businesses, individuals and academia who provide goods and services to New Jersey’s life sciences companies.

The NJLSVA was founded to educate suppliers on trends in industry procurement and public policy that affects the life sciences industry.


Hackensack University Medical Center Foundation Receives Donation from Celgene to Advance Multiple Myeloma Research at John Theurer Cancer Center

Former Roche campus to be new Seton Hall-Hackensack Meridian School of Medicine

Hackensack, NJ, October 20, 2017 — The Hackensack University Medical Center Foundation announced on October 5 that it has received a substantial donation from Celgene Corporation to advance multiple myeloma research and transformational medicine that improve patient outcomes at Hackensack Meridian Health–John Theurer Cancer Center.

Supported by Celgene, a global biopharmaceutical leader in the discovery, development and delivery of treatment for diseases like multiple myeloma (MM), funds will help to establish the Multiple Myeloma Institute (MMI) — a leading-edge research facility at the Seton Hall-Hackensack Meridian School of Medicine scheduled to open in 2018.

Celgene and John Theurer Cancer Center are accomplished leaders in developing novel therapies for patients with multiple myeloma. Continue reading

Rutgers Merges Graduate School-New Brunswick and Graduate School of Biomedical Sciences

Trenton, NJ, April 11, 2017 — Rutgers’ Graduate School-New Brunswick and the Graduate School of Biomedical Sciences — among the leading research graduate schools in the United States — will join forces and become the School of Graduate Studies, an initiative first conceived as part of the 2013 integration between Rutgers and the University of Medicine and Dentistry of New Jersey.

The Board of Governors voted on Thursday to create the new School of Graduate Studies, which will serve about 5,100 students.

It will include 63 doctoral programs and 75 master’s degree programs in humanities, social sciences, physical sciences, mathematical sciences, biological and medical sciences and engineering. Continue reading

Rutgers-Chaired Study Committee Announces Recommendations for Eliminating Viral Hepatitis

Dr. Brian Strom

New Brunswick, NJ, March 29, 2017 — Viral hepatitis could become rare — and approximately 20,000 deaths annually in the U.S. could be eliminated — if federal and state agencies make the disease a priority, according to recommendations of the National Academies of Sciences, Engineering, and Medicine announced today in Washington, D.C.

“Many people suffering from viral hepatitis are not in contact with the health system, so the elimination strategy must give as much attention to the delivery of services as to the services themselves,” said Brian L. Strom, M.D., M.P.H., a renowned epidemiologist and the chancellor of Rutgers Biomedical and Health Sciences, who headed the committee of scientists selected by the Academies which studied the issue and developed the recommendations. Continue reading

NJIT’s Biomedical Engineering Program Ranked #1 Best Value in New Jersey

Newark, NJ, March 28, 2017 — The New Jersey Institute of Technology (NJIT) offered the best value biomedical engineering program in 2016 for undergrads in New Jersey according to BestValueSchools.com.

This program is also ranked eighth nationally. NJIT’s biomedical engineering program is part of the Newark College of Engineering (NCE), the oldest and largest professional engineering school in the United States. Continue reading

NJIT Biomedical Engineers Showcase Research at the National Neurotrauma Society Symposium

Newark, NJ, August 21NJIT Logo, 2016 ― Researchers from the New Jersey Institute of Technology (NJIT) Department of Biomedical Engineering and the Center for Injury Bio-mechanics, Materials, and Medicine (CIBM3) featured their work on traumatic brain injury (TBI) at the National Neurotrauma Society (NNS) Symposium in June.

Since its inception in 1982, the NNS symposium has served as the premier forum for the exchange of ideas and information related to TBI and spinal cord injury (SCI).

With its focus on integrating clinical, translational and basic science on neurotrauma-related research, combined with the meeting location in Lexington, Ky., the horse capital of the world, this year’s theme was: “The Triple Crown: Advances in Basic Sciences, Pre-Clinical Modeling and Clinical Approaches.” Continue reading

Rutgers Names Brian Strom as Chancellor of Biomedical and Health Sciences

New Brunswick, NJ, July 19, 2013 — Rutgers University President Robert L. Barchi yesterday announced the appointment of Brian L. Strom, M.D., M.P.H. — a renowned epidemiologist, award-winning teacher and clinician, and longtime academic leader at the University of Pennsylvania — as the inaugural chancellor of Rutgers Biomedical and Health Sciences (RBHS).  Dr. Strom will begin on December 2.

In making the announcement, President Barchi said, “I have known Dr. Strom for many years.  He is an internationally recognized scholar and researcher, a distinguished educator and a proven academic administrator.  His leadership will guide Rutgers Biomedical and Health Sciences during this unprecedented transition and establish RBHS as a model for research and education in the biomedical and health sciences.  Brian has enjoyed a remarkable career at Penn, and his vision and leadership will be invaluable as the new Rutgers transforms higher education in New Jersey.” Continue reading